Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00082173 |
Recruitment Status :
Completed
First Posted : May 4, 2004
Results First Posted : May 22, 2013
Last Update Posted : May 22, 2013
|
Sponsor:
Johns Hopkins University
Information provided by:
Johns Hopkins University
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment |
Condition |
Tuberculosis |
Intervention |
Drug: Moxifloxacin |
Enrollment | 170 |
Participant Flow
Recruitment Details | Subjects with respiratory symptoms suggestive of TB were recruited from the HUCFF outpatient TB clinic as well as other local TB clinics. |
Pre-assignment Details | Patients who did not meet enrollment criteria or who did not want to participate in the study were excluded. |
Baseline Characteristics
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title: | Dr. Richard Chaisson |
Organization: | Johns Hopkins University |
Phone: | 410-955-1755 |
EMail: | rchaiss@jhmi.edu |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Dr. Richard E. Chaisson, Johns Hopkins University |
ClinicalTrials.gov Identifier: | NCT00082173 History of Changes |
Other Study ID Numbers: |
FD-R-002135-01 |
First Submitted: | April 30, 2004 |
First Posted: | May 4, 2004 |
Results First Submitted: | March 26, 2013 |
Results First Posted: | May 22, 2013 |
Last Update Posted: | May 22, 2013 |